Tenet Healthcare Corp. (THC) Misses Q4 EPS by 4c; Raises FY12 EBITDA Outlook
Tweet
Share
E-mailGet Alerts THC Hot Sheet
Price: $174.66 +0.86%
Revenue Growth %: +2.8%
Financial Fact:
Income tax benefit (expense): -1M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +2.8%
Financial Fact:
Income tax benefit (expense): -1M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Tenet Healthcare Corp. (NYSE: THC) reported Q4 EPS of $0.10, $0.04 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $2.23 billion versus the consensus estimate of $2.4 billion.
Raised its FY12 adj-EBITDA guidance from $1.2-$1.3 billion to $1.225-$1.35 billion.
For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.
Raised its FY12 adj-EBITDA guidance from $1.2-$1.3 billion to $1.225-$1.35 billion.
For earnings history and earnings-related data on Tenet Healthcare Corp. (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- BIG3 Basketball to go public via Graf Global merger at $290 million
- Aspire Biopharma to acquire automotive supplier for $30 million
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
